Astaxanthin is associated with improved cerebral perfusion and exploratory hippocampal phospholipid alterations in chronic cerebral hypoperfusion

The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3

10.1038/s41467-021-27244-1 · doi-reference

Brain lipidomics: From functional landscape to clinical significance

10.1126/sciadv.adc9317 · doi-reference

Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A

10.1038/s41586-021-03782-y · doi-reference

Astaxanthin rescues memory impairments in rats with vascular dementia by protecting against neuronal death in the hippocampus

10.1007/s12017-024-08796-z · doi-reference

Plasmalogen in the brain: Effects on cognitive functions and behaviors attributable to its properties

10.1016/j.brainresbull.2022.08.008 · doi-reference

Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats

10.1016/j.bcp.2022.114980 · doi-reference

LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis

10.1021/acschembio.2c00317 · doi-reference

Chronic cerebral hypoperfusion: A critical feature in unravelling the etiology of vascular cognitive impairment

10.1186/s40478-023-01590-1 · doi-reference

Lipidome atlas of the adult human brain

10.1038/s41467-024-48734-y · doi-reference

Lipid flipping in the omega-3 fatty-acid transporter

10.1038/s41467-023-37702-7 · doi-reference

Adenosine A2A receptor in bone marrow-derived cells mediated macrophages M2 polarization via PPARγ-P65 pathway in chronic hypoperfusion situation

10.3389/fnagi.2021.792733 · doi-reference

Adiponectin ameliorates hypoperfusive cognitive deficits by boosting a neuroprotective microglial response

10.1016/j.pneurobio.2021.102125 · doi-reference

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy

10.1016/j.phrs.2022.106482 · doi-reference

2-(4-Methylthiazol-5-yl) ethyl nitrate hydrochloride ameliorates cognitive impairment via modulation of oxidative stress and nuclear factor kappa B signaling pathway in chronic cerebral hypoperfusion-associated spontaneously hypertensive rats

10.3390/antiox13050585 · doi-reference

The lipidomics reporting checklist: A framework for transparency of lipidomic experiments and repurposing resource data

10.1016/j.jlr.2024.100621 · doi-reference

Recommendations for good practice in MS-based lipidomics

10.1016/j.jlr.2021.100138 · doi-reference

A circRNA ceRNA network involved in cognitive dysfunction after chronic cerebral hypoperfusion

10.18632/aging.205387 · doi-reference

A brief overview of a mouse model of cerebral hypoperfusion by bilateral carotid artery stenosis

10.1177/0271678x231154597 · doi-reference

Phospholipidomics in clinical trials for brain disorders: Advancing our understanding and therapeutic potentials

10.1007/s12035-023-03793-y · doi-reference

Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species

10.3389/fcell.2022.866156 · doi-reference

Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment

10.1002/alz.13408 · doi-reference

Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent

10.3390/md19040201 · doi-reference